by Heidi Stevenson
Originally posted November 2009
A new neurological disease, which is almost certainly caused by aluminum adjuvants in vaccines, is characterized by severe muscle and joint pain, inflammation with fever, and debilitating fatigue. Macrophagic myofasciitis (MMF), which is similar to, but diagnostically distinct from, fibromyalgia was first identified in 1993. Because adjuvant aluminum is the probable cause of MMF, some researchers have suggested that it may also be the cause of fibromyalgia.
Many of the old time clinicians have known for decades that Multiple Sclerosis is caused by Vitamin D deficiency and MS patients benefit from taking Vitamin D. Perhaps some MS patients have been cured simply by taking sufficient quantities of Vitamin D.
Above left image: Multiple Sclerosis. Animated Brain CAT scans one month apart, showing migratory enhancing white matter lesions in the periventricular area, changing with time, courtesy of wikimedia commons.(2) (more…)
There are many people, an estimated 350,000 people in the United States that are living with this painful, debilitating, and sometimes fatal disorder of the central nervous system. Western medicine has not come up with good treatment strategies for this disease and the United States government keeps one of the safest and most helpful medicines for this population illegal. Seems they could care less and would doom this population to perpetual suffering. (more…)
Although MS was first described over 130 years ago, the exact cause(s) still remain a mystery, and there is no known cure. The term “multiple sclerosis” refers to two characteristics of the disease: the numerous affected areas of the brain and spinal cord producing multiple neurologic symptoms that accrue over time, and the characteristic plaques or sclerosed areas that are the hallmark of the disease. MS is usually diagnosed in individuals between the ages of 20 and 45 years (although cases in children have been reported), with peak incidence occurring in the fourth decade. MS is, in general, a disease of temperate climates. In both hemispheres, its prevalence increases with distance from the equator. The highest known prevalence (250 per 100,000) occurs in the Orkney Islands, located north of the mainland of Scotland. Multiple sclerosis is also common in Scandinavia and throughout northern Europe. (more…)
Imagine watching a woman with multiple sclerosis of many years duration (who had previously needed a “walker” to help her get around) walking unaided several times around a room at good speed, and with no balance problems. Imagine listening to her say she’s sleeping better, her energy is much improved, and that she’s able to think more clearly. She attributes her dramatic improvement to the natural amino acid derivative she’s been using for the previous two to three weeks. Imagine hearing another woman, much more seriously afflicted, report that she’s able to feed herself again, and that her friends and relatives had all noticed her speech is easier to understand. Both of these improvements occurred within a month of starting the “new” natural amino acid derivative. (more…)